Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/26/2024 | $6.50 → $1.25 | Overweight → Equal-Weight | Morgan Stanley |
1/3/2024 | $8.00 | Underweight | Barclays |
12/20/2023 | $14.00 | Buy | Guggenheim |
9/27/2023 | $4.00 → $10.00 | Sell → Hold | Craig Hallum |
7/26/2023 | $5.00 → $13.00 | Equal-Weight → Overweight | Morgan Stanley |
4/11/2023 | $3.80 → $13.00 | Neutral → Buy | Goldman |
3/8/2023 | $4.00 | Hold → Sell | Craig Hallum |
3/3/2022 | $30.00 → $20.00 | Buy | DA Davidson |
Gainers Barnes & Noble Education (NYSE:BNED) stock rose 11.1% to $0.5 during Friday's after-market session. The company's market cap stands at $26.5 million. Yatra Online (NASDAQ:YTRA) shares rose 5.46% to $1.35. The market value of their outstanding shares is at $86.8 million. Neo-Concept International (NASDAQ:NCI) stock increased by 4.99% to $0.76. The market value of their outstanding shares is at $15.3 million. Qurate Retail (NASDAQ:QRTEA) shares increased by 4.97% to $0.75. The company's market cap stands at $296.4 million. SRM Entertainment (NASDAQ:SRM) stock rose 3.9% to $1.33. The market value of their outstanding shares is at $13.5 million. Sacks Parente Golf (NASDAQ:SPGC) sha
Gainers Funko (NASDAQ:FNKO) stock rose 13.6% to $7.75 during Thursday's after-market session. The company's market cap stands at $415.0 million. As per the press release, Q1 earnings came out today. Interactive Strength (NASDAQ:TRNR) shares rose 10.03% to $0.17. The company's market cap stands at $3.3 million. Sweetgreen (NYSE:SG) stock moved upwards by 5.51% to $24.86. The company's market cap stands at $2.8 billion. The company's, Q1 earnings came out today. Groupon (NASDAQ:GRPN) stock moved upwards by 4.71% to $11.0. The market value of their outstanding shares is at $430.0 million. As per the press release, Q1 earnings came out today. Rent the Runway (NASDAQ:RENT) shares moved upwar
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)
SC 13G - WW INTERNATIONAL, INC. (0000105319) (Subject)
10-Q - WW INTERNATIONAL, INC. (0000105319) (Filer)
8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
8-K - WW INTERNATIONAL, INC. (0000105319) (Filer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
4 - WW INTERNATIONAL, INC. (0000105319) (Issuer)
Independent Board Member Tara Comonte Will Serve as Interim Chief Executive OfficerSima Sistani Will Step Down as CEO and Director NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") announced today that WeightWatchers Board member Tara Comonte has been appointed Interim Chief Executive Officer. Ms. Comonte succeeds Sima Sistani, who departs from her role as Chief Executive Officer and as a member of the Board, effective today. During her tenure, Ms. Sistani led the Company's transformation to a modern digital health organization and extended the Company's portfolio of solutions into the telehealth space with the acqu
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ:WW), ("WeightWatchers," "WW," or the "Company") announced today the appointments of Scott Honken as Chief Commercial Officer and Phillip Picardi as Chief Impact Officer. The two will collaborate, alongside the existing leadership team to redefine community engagement across all stakeholders, including a continued focus on B2B constituents of employers, payers, and health plans and expanding access through WeightWatchers for Business. "Scott and Phillip will propel us forward as we embark upon a new chapter of growth for WeightWatchers," said Sima Sistani, CEO WeightWatchers. "Their expertise engaging communities and accel
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW), ("WeightWatchers," "WW," or the "Company"), announced today a live virtual event, hosted by global media leader Oprah Winfrey, "Making The Shift: A New Way to Think About Weight." The event will take place on Thursday, May 9, from 6 to 9 p.m. ET, and will include a live studio and live global virtual audience, and will be live streamed on WeightWatchers YouTube channel. Joining the conversation are diverse and influential voices, including Rebel Wilson, Amber Riley, Katie Sturino, Marisa Meltzer, Jamie Kern Lima, Tressie McMillan Cottom, along with leading science and medical experts, Dr. Rachel Goldman, Dr. A
Morgan Stanley downgraded WW from Overweight to Equal-Weight and set a new price target of $1.25 from $6.50 previously
Barclays initiated coverage of WW with a rating of Underweight and set a new price target of $8.00
Guggenheim resumed coverage of WW with a rating of Buy and set a new price target of $14.00
End of Period Subscribers of 3.7 millionRevenues of $192.9 millionGross margin of 67.1%; adjusted gross margin of 69.1%Operating Loss of $39.0 million; adjusted operating income of $35.7 million NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") today announced its results for the third quarter of fiscal 2024. "For over six decades, WeightWatchers has been the trusted leader in weight management, offering a full spectrum of science-backed, proven weight management solutions. With our expanded clinical offering, iconic trusted brand, and global community of members, we are well-equipped to succeed in today's rapidly ev
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or "the Company") will release its results for the third quarter 2024 before market open on Wednesday, November 6, 2024. WeightWatchers will host a conference call at 8:30 a.m. ET the same day. During the conference call, Tara Comonte, Interim President and Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the third quarter 2024 results and answer questions from the investment community. The live webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. Supplemental investor mat
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") announced today the addition of compounded semaglutide into its offering, broadening eligible members' access to clinical weight management interventions that are underpinned by the comprehensive, science-backed, behavioral and lifestyle support that has helped millions of people reach and sustain their weight goals. "At WeightWatchers, we have always combined proven science and personalized support to help our members achieve meaningful, lasting results. With the addition of compounded semaglutide, we are expanding our offering to include a clinical weight management solution
End of Period Subscribers of 3.7 millionRevenues of $192.9 millionGross margin of 67.1%; adjusted gross margin of 69.1%Operating Loss of $39.0 million; adjusted operating income of $35.7 million NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or the "Company") today announced its results for the third quarter of fiscal 2024. "For over six decades, WeightWatchers has been the trusted leader in weight management, offering a full spectrum of science-backed, proven weight management solutions. With our expanded clinical offering, iconic trusted brand, and global community of members, we are well-equipped to succeed in today's rapidly ev
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("WeightWatchers," "WW," or "the Company") will release its results for the third quarter 2024 before market open on Wednesday, November 6, 2024. WeightWatchers will host a conference call at 8:30 a.m. ET the same day. During the conference call, Tara Comonte, Interim President and Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the third quarter 2024 results and answer questions from the investment community. The live webcast of the conference call will be available on the Company's corporate website, corporate.ww.com, under Events and Presentations. Supplemental investor mat
End of Period Subscribers of 3.8 million, including 81 thousand End of Period Clinical SubscribersRevenues of $202.1 millionGross margin of 67.9%Operating Income of $35.9 million; excluding the net impact of restructuring charges related to prior year restructuring plans, adjusted operating income of $37.9 millionProvides update to full year fiscal 2024 guidanceAnnounces 2024 Restructuring Plan that is expected to result in $100 million of annual run-rate cost savings related to strategic streamlining of the Company's operational structure to optimize its clinical and behavioral product portfolio and to its cost-savings initiative NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- WW Int